M&A Deal Summary |
|
|---|---|
| Date | 2013-01-21 |
| Target | Lundbeck - Portfolio Of Products |
| Sector | Medical Products |
| Buyer(s) | Recordati |
| Sellers(s) | H. Lundbeck |
| Deal Type | Divestiture |
| Deal Value | 100M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1926 |
| Sector | Medical Products |
| Employees | 4,455 |
| Revenue | 2.1B EUR (2023) |
Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 17 |
| Sector (Medical Products) | 4 of 5 |
| Type (Divestiture) | 2 of 2 |
| Country (United States) | 1 of 1 |
| Year (2013) | 1 of 4 |
| Size (of disclosed) | 6 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-23 |
Farma-Projekt Sp. z o.o.
Krakow, Poland Farma-Projekt Sp. z o.o. is a Polish pharmaceutical company market since 2003 and markets drugs belonging to a variety of therapeutic areas, mainly cardiovascular and urological treatments as well as dietary supplements. |
Buy | zł71M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-09 |
Laboratorios Casen Fleet S.L.U.
Pozuelo de Alarcón, Spain Laboratorios Casen Fleet, S.L.U. is a Spanish pharmaceutical company. |
Buy | €93M |
| Category | Company |
|---|---|
| Founded | 1915 |
| Sector | Healthcare Services |
| Employees | 5,681 |
| Revenue | 19.9B DKK (2023) |
H. Lundbeck A/S is an international pharmaceutical company engaged inthe research and development, production, marketing and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. H. Lundbeck was founded in 1915 and is based in Valby, Denmark.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2013) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-03-19 |
Ovation Pharmaceuticals
Deerfield, Illinois, United States Ovation Pharmaceuticals is a specialty pharmaceutical company focused on acquiring underpromoted branded pharmaceutical products and promising late-stage development products. Ovation increases the sales of its acquired products through the implementation of active selling efforts, creative marketing programs, and through product life cycle activities that are focused on developing new formulations, new indications, and other product improvements. Ovation is led by CEO Jeff Aronin and Executive Chairman Bill Gantz. |
Buy | $900M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-06-24 |
Chelsea Therapeutics International
Charlotte, North Carolina, United States Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. |
Buy | $658M |
